glp 1 diets Cigna drops employee coverage of GLP-1 obesity drugs Weight loss drugs' high costs

Olympia Vita Complex: Helps reduce excess fatigue caused by dehydration

In adults with overweight or obesity (without diabetes) the semaglutide 2.4 mg dose produced an average weight reduction of about 15% of baseline body weight over ~68 weeks in the STEP 1 trial, a result that surprised many clinicians because it brought pharmacologic outcomes into a range previously associated with surgical interventions

Chronic stress increases cortisol, which can inhibit GLP-1

Our therapists use proven methods to teach communication, improve social skills, and reduce challenging behaviors, while working closely with families for the best outcomes